Lilly Launches Humalog® Mix50/50 Insulin in United States

Why bother to be interested in Lilly’s re-introduction of Humalog 50/50? I look forward to this as it comes closer to mimicking the bodies own insulin release, and for my patients it reduces the chance of nocturnal hypoglycemia. Learn more about how this formulation makes a difference by checking out our newsflash. Lilly Launches Humalog® Mix50/50 Insulin in United States
Pre-mixed insulin gives patients improved blood sugar control after meals

Different people with diabetes have different insulin needs, and last Tuesday Eli Lilly and Company (NYSE: LLY) announces the launch of a new pre-mixed insulin, Humalog® Mix50/50 (50% insulin lispro protamine suspension, 50% insulin lispro injection (rDNA origin)). Humalog Mix50/50 is for use in patients with diabetes to control high blood sugar and is available in an easy-to-use pen delivery device.

Humalog Mix50/50 is designed to provide blood sugar control between meals but also includes a higher percentage of rapid-acting insulin for people with diabetes who need more insulin control at mealtime. The Humalog component starts lowering blood sugar more quickly than regular human insulin, allowing for convenient dosing immediately before a meal (within 15 minutes). Humalog Mix50/50 provides doctors with an additional tool to help their patients better manage blood sugar after meals.

Ron Hoven, diabetes care marketing director, Eli Lilly and Company states that. “Some people with diabetes try to make an effort but are busy and dont always eat balanced meals. For those who need improved blood sugar control at mealtime while also balancing their blood sugar between meals, Humalog Mix50/50 may provide a new solution.”

Humalog Mix50/50 is available now and comes in a prefilled pen.

Diabetes In Control will have a complete guide to prescribing mixed insulin and the differences in an upcoming issue.